May 1, 2014 by Michael Douglass and Dave WilliamsonUp 50%: Merrimack Pharmaceuticals' Groundbreaking NewsA great day for shareholders of this company. Here's what's behind the big pop.
May 1, 2014 by Michael Douglass and Dave WilliamsonWhy This Company Isn't Joining the Merger BlitzIs this good strategy?
Apr 30, 2014 by Michael Douglass and Mark ReethShould You Buy WellPoint Today?The stock is up after reporting an interesting first quarter.
Apr 29, 2014 by Michael Douglass and Dave WilliamsonDividend Stock Merck's Incoming PaydayJust how much could the consumer care division bring in?
Apr 29, 2014 by Michael Douglass and Dave WilliamsonWill Allergan Buy Its Way out of a Takeover?Spending billions to save hundreds (of jobs)
Apr 29, 2014 by Michael Douglass and Dave WilliamsonMassive Swings: Biota Pharmaceuticals, Inc. and Amicus Therapeutics, Inc.Big moves from two tiny stocks: what is a Foolish investor to do?
Apr 29, 2014 by Michael Douglass and Dave WilliamsonThe 3 Reasons Pfizer Wants AstraZenecaDoes the proposed Pfizer Acquisition of AstraZeneca make sense? Pfizer management thinks so -- for these three reasons.
Apr 29, 2014 by Michael Douglass and Dave WilliamsonWhy Did Forest Laboratories Buy Furiex Pharmaceuticals?Forest Laboratories bought Furiex Pharmaceuticals. Smart move?
Apr 28, 2014 by Michael Douglass and Dave WilliamsonDown 60%: Is OncoGenex a Bad News Buy?OncoGenex got crushed today. Is there some light at the end of the tunnel?
Apr 27, 2014 by Michael Douglass and Dave WilliamsonThis Dividend Stock Had a Great QuarterAetna had a great first quarter. Let's see why.
Apr 27, 2014 by Michael Douglass and Dave WilliamsonAbbVie, Inc's Earnings Made EasyAbbVie reported first quarter 2014 earnings this past week. Let's dive in to what the company reported.
Apr 26, 2014 by Michael Douglass and Dave WilliamsonHas Obamacare's Harshest Critic Changed His Tune?A potential change of heart driven by excellent first quarter numbers.
Apr 25, 2014 by Michael Douglass and Dave WilliamsonDo These Multi-Billion Dollar Drug Deals Make Sense?Move aside, earnings: Potentially bigger news in big pharma this week.
Apr 25, 2014 by Michael Douglass and Dave WilliamsonEarnings Made Easy: AstraZeneca plcFresh off the buyout rumors, AstraZeneca reports first quarter earnings.
Apr 21, 2014 by Michael Douglass and Max MacalusoCan This Dow Dividend Stock Recover from Disappointing Earnings?UNH declined substantially on Friday despite a beat on the bottom line and a slight miss on revenue: What happened?
Apr 19, 2014 by Michael Douglass and Dave WilliamsonObamacare Expands: What You Need to KnowCBO estimates that Obamacare will cost $104 billion less than initially projected. But that isn't the most important number for investors.
Apr 17, 2014 by Michael Douglass and Dave WilliamsonIs Herbalife a Bad News Buy?The hits keep on coming for this struggling stock. What should investors do?
Apr 16, 2014 by Michael Douglass and Dave WilliamsonJohnson and Johnson Earnings Surprises With Blockbuster Potential11% growth in pharmaceuticals drives top-line growth at JNJ. But one drug really stole the show.
Apr 13, 2014 by Michael Douglass and Dave WilliamsonExpress Scripts' Obamacare Data: What You Need to KnowInteresting news from Express Scripts' newly available data.
Apr 13, 2014 by Michael Douglass and Dave WilliamsonIs Now a Good Time to Buy Intuitive Surgical Inc Stock?Intuitive Surgical had a rough week after pre-releasing less-than-stellar earnings. What's next for the stock?
